The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-operative intratumoral toll-like receptor 9 (TLR9) agonist vidutolimod (Vidu) and stereotactic body radiation therapy (SBRT) in early triple-negative breast cancer (eTNBC): Randomized phase 2 CyberImmunoBreast trial.
 
Khalil Zaman
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)
Other Relationship - Daiichi Sankyo Europe GmbH (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst)
 
Stephanie Tissot
No Relationships to Disclose
 
Estelle Dubruc
No Relationships to Disclose
 
Ourania Dafni
No Relationships to Disclose
 
Wendy Jeanneret Sozzi
No Relationships to Disclose
 
Rami Hajri
No Relationships to Disclose
 
Loïc Lelièvre
No Relationships to Disclose
 
David Tarussio
No Relationships to Disclose
 
Petra Baumgaertner
No Relationships to Disclose
 
Jonathan Thevenet
No Relationships to Disclose
 
Magdalini Kypriotou
No Relationships to Disclose
 
Julie Chenal
No Relationships to Disclose
 
Audrey Goupil
No Relationships to Disclose
 
Bernhard Gentner
Stock and Other Ownership Interests - Genenta Science
Consulting or Advisory Role - Genenta Science
Patents, Royalties, Other Intellectual Property - Genenta Science
 
Athina Stravodimou
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi Sankyo (Inst); Exact Sciences (Inst); Gilead, Lilly (Inst); Novartis (Inst); Roche Africa (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo (Inst); Exact Sciences (Inst); Gilead Sciences (Inst); Lilly (Inst); MSD (Inst); Pfizer (Inst)
 
Jean Bourhis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD
 
George Coukos
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - EVIR (Inst); Iovance Biotherapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Ludwig Institute for Cancer Research, the University of Lausanne and the CHUV - Tigen Pharma; University of Pennsylvania Health System - Novartis and Tmunity Therapeutics
 
Pelagia Tsoutsou
No Relationships to Disclose